Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,000 | 0 | 297 | 3,942 | 2,296 |
| Gross Profit | 2,000 | N/A | 297 | 3,942 | 2,296 |
| Operating Expenses | 5,628 | 12,951 | 18,837 | 59,137 | 83,561 |
| Operating Income | -3,628 | -12,951 | -18,540 | -55,195 | -81,265 |
| Other Income | 571 | 358 | 294 | 3,548 | 3,463 |
| Pre-tax Income | -3,057 | -12,593 | -18,246 | -51,647 | -77,802 |
| Net Income Continuous | -3,057 | -12,593 | -18,246 | -51,647 | -77,802 |
| Net Income Discontinuous | N/A | 7,330 | -25,832 | N/A | N/A |
| Net Income | $-3,057 | $-5,263 | $-44,078 | $-51,647 | $-77,802 |
| EPS Basic Total Ops | -1.21 | -2.25 | -20.28 | -26.40 | -51.20 |
| EPS Basic Continuous Ops | -1.21 | -5.39 | -8.40 | -26.39 | -51.18 |
| EPS Basic Discontinuous Ops | N/A | 3.14 | -11.89 | N/A | N/A |
| EPS Diluted Total Ops | -1.21 | -2.25 | -20.28 | -26.40 | -51.20 |
| EPS Diluted Continuous Ops | -1.21 | -5.39 | -8.40 | -26.39 | -51.18 |
| EPS Diluted Discontinuous Ops | N/A | 3.14 | -11.89 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.21 | -3.98 | -20.20 | -26.40 | -51.20 |
| EBITDA(a) | $-3,628 | $-12,951 | $-18,475 | $-54,723 | $-78,968 |